scholarly journals Endocrine disrupting‐chemicals and biochemical recurrence of prostate cancer after prostatectomy: A cohort study in Guadeloupe (French West Indies)

2019 ◽  
Vol 146 (3) ◽  
pp. 657-663 ◽  
Author(s):  
Laurent Brureau ◽  
Elise Emeville ◽  
Carole Helissey ◽  
Jean Pierre Thome ◽  
Luc Multigner ◽  
...  
Author(s):  
Linda Titus

Abstract This review summarizes key findings from the US National Cancer Institute (NCI) DES Combined Cohort Study with a focus on the results of the NCI Third Generation Study, a cohort of DES-exposed and unexposed granddaughters. Findings to date from the Third Generation Study are discussed in the context of other research efforts and case reports suggesting an intergenerational heritability of DES-related effects. The DES story serves as a model for the influence of endocrine disrupting chemicals on human health. It also serves as a warning of the special hazards of pregnancy exposures, and more broadly, of the potential for invisible health consequences arising from new or changing exposures.


Author(s):  
Jane A. Plant ◽  
Devra L. Davis

Cancers of the breast and prostate, which together with those of the ovaries, endometrium and testes are hormone-dependent, are among the most common forms of cancers affecting women and men respectively throughout the developed world (IARC VII 1997, Miller and Sharp 1998). The incidence of breast, prostate, and testicular cancers has risen dramatically in most European and North American countries and in Japan and Australasia since cancer registries were first compiled in the 1960s (WHO/IARC Web site). For instance, women and men born in Generation X in the U.S. and Europe today have twice the risk of developing breast and prostate cancer than their grandparents faced (Dinse et al. 1999). Several lines of evidence indicate that environmental factors, broadly conceived, may account for some of the recent changes in patterns of hormonally dependent cancers. Although rates are about 4 times lower in Asian countries than in European ones, they are increasing most rapidly in the former (Hoel et al. 1992). People who migrate tend to develop the cancer rate of their new countries. Studies of highly exposed workers consistently find that those working with certain plastics, organic solvents, pesticides, and other toxic chemicals tend to have higher risks of several hormonally dependent cancers (Davis and Muir 1995). Dietary factors can be involved in these patterns in two ways. Food constituents, such as dairy and animal protein products, can affect hormonal metabolism directly. In addition, foods can contain contaminants such as growth stimulating substances, pesticides, and packaging materials that can function as endocrine disrupting chemicals (EDCs). In the past decade, a number of major national and international reports have noted the possible role of EDCs for hormone-related illnesses including breast and prostate cancer, including the Weybridge report of the European Environment Agency of 1996 (EUR 17549 1997) and the Royal Society Report on Endocrine Disrupting Chemicals (Royal Soc. 2000). This chapter presents some recent information on the sources of EDCs in the environment, outlines mechanisms by which these materials can increase the risk of hormonally dependent cancers, and discusses insights from geochemistry that may be pertinent to this work.


BMJ Open ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. e025161
Author(s):  
Mark Rezk ◽  
Ashish Chandra ◽  
Daniel Addis ◽  
Henrik Møller ◽  
Mina Youssef ◽  
...  

ObjectivesTo determine whetherETS-related gene(ERG) expression can be used as a biomarker to predict biochemical recurrence and prostate cancer-specific death in patients with high Gleason grade prostate cancer treated with androgen deprivation therapy (ADT) as monotherapy.MethodsA multicentre retrospective cohort study identifying 149 patients treated with primary ADT for metastatic or non-metastatic prostate cancer with Gleason score 8–10 between 1999 and 2006. Patients planned for adjuvant radiotherapy at diagnosis were excluded. Age at diagnosis, ethnicity, prostate-specific antigen and Charlson-comorbidity score were recorded. Prostatic tissue acquired at biopsy or transurethral resection surgery was assessed for immunohistochemical expression ofERG. Failure of ADT defined as prostate specific antigen nadir +2. Vital status and death certification data determined using the UK National Cancer Registry. Primary outcome measures were overall survival (OS) and prostate cancer specific survival (CSS). Secondary outcome was biochemical recurrence-free survival (BRFS).ResultsThe median OS of our cohort was 60.2 months (CI 52.0 to 68.3).ERGexpression observed in 51/149 cases (34%). Multivariate Cox proportional hazards analysis showed no significant association betweenERGexpression and OS (p=0.41), CSS (p=0.92) and BRFS (p=0.31). Cox regression analysis showed Gleason score (p=0.003) and metastatic status (p<1×10-5) to be the only significant predictors of prostate CSS.ConclusionsNo significant association was found betweenERGstatus and any of our outcome measures. Despite a limited sample size, our results suggest thatERGdoes not appear to be a useful biomarker in predicting response to ADT in patients with high risk prostate cancer.


2019 ◽  
Vol 27 (33) ◽  
pp. 40992-40998
Author(s):  
Florence Rouget ◽  
Philippe Kadhel ◽  
Christine Monfort ◽  
Jean François Viel ◽  
Jean Pierre Thome ◽  
...  

2002 ◽  
Vol 10 (2) ◽  
pp. 77-100
Author(s):  
PA Fowler ◽  
T Murray ◽  
DR Abramovich ◽  
N Haites ◽  
RG Lea

There have been a number of reviews on this topic over the past decade, starting with Carlsen et al. and including Irvine et al. and Murray et al., concerning declining male fertility. The most exhaustive has perhaps been that of Toppari et al. The main findings of these reviews are: (1) that in some countries of the world sperm production has halved in the last 60 years, (2) rates of testicular cancer have doubled, (3) rates of malformation of the male reproductive tract, such as hypospadias, have doubled, (4) rates of testicular maldescent have risen sharply and (5) these effects are largely linked geographically. Typically, endocrine disrupting chemicals (EDCs) in the environment have been regarded as the main candidates for these effects. A consistent problem with the field, however, is the difficulty in determining the accuracy of data relating to changes in men's health over the latter half of the 20th century. Advances in diagnosis and changing attitudes to the emotive issues surrounding deformity and male infertility inevitably render some of the mass of collected data suspect. Indeed a recent review of testicular and prostate cancer concluded that while the incidence of prostate cancer had increased, the epidemiological data were not suitable for concrete conclusions about causation to be drawn. However, in the case of testicular cancer the data suggested a limited number of major risk factors. In addition, assessing urogenital malformation retrospectively from patient notes is subject to considerable variation in classification. A recent review does however find evidence to suggest that trends of increasing incidences of hypospadias on a temporal and geographical basis may reflect an actual increase in incidence and require further study. On the other hand, there is a considerable body of evidence for EDC disruption of reproduction in wildlife (reviewed by Guillette & Gunderson, 2001).


2015 ◽  
Vol 17 (1) ◽  
pp. 117 ◽  
Author(s):  
Geraldine Cancel-Tassin ◽  
Marc Romana ◽  
Cecile Gaffory ◽  
Pascal Blanchet ◽  
Olivier Cussenot ◽  
...  

2016 ◽  
Vol 67 (2) ◽  
pp. 83-92 ◽  
Author(s):  
Vesna Zadnik ◽  
Mateja Krajc

AbstractThe incidence of hormone-related cancers tends to be higher in the developed world than in other countries. In Slovenia, six hormone-related cancers (breast, ovarian, endometrial, prostate, testicular, and thyroid) account for a quarter of all cancers. Their incidence goes up each year, breast and prostate cancer in particular. The age at diagnosis is not decreasing for any of the analysed cancer types. The risk of breast cancer is higher in the western part of the country, but no differences in geographical distribution have been observed for other hormone-related cancers. Furthermore, areas polluted with endocrine-disrupting chemicals that affect hormone balance such as PCBs, dioxins, heavy metals, and pesticides, do not seem to involve a greater cancer risk. We know little about how many cancers can be associated with endocrine disruptors, as there are too few reliable exposure studies to support an association.


Sign in / Sign up

Export Citation Format

Share Document